ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study (2020)
Attributed to:
Large-scale integrative studies of risk factors in coronary heart disease: from discovery to application
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.04.10.20059121
Publication URI: http://dx.doi.org/10.1101/2020.04.10.20059121
Type: Preprint